First, it is important to understand that it is not among the drugs screened for in a standard drug test
Diabetes 46(1):310 Boulang CL, Neves AL, Chilloux J, Nicholson JK, Dumas M-E (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease
GI symptoms (nausea, bloating, or diarrhea) are common, especially early on
In the SUSTAIN-1 trial (N=388), diarrhea occurred in 8.5% of participants receiving semaglutide 1 mg versus 1.2% on placebo 2
Studies show that GLP-1 in adults used with lifestyle changes, showed an average weight loss of about 6% of initial body weight over 12 weeks, and 12% was achieved by week 28
Clinical pharmacology of antidiabetic drugs: what can be expected of their use